Tanshinone IIA improves endoplasmic reticulum stress-induced insulin resistance through AMP-activated protein kinase

Biochemical and Biophysical Research Communications

Volumn 430, Issue 4, 2013, Pages 1246-1252

  Hwang, Seung Lark ^a   Yang, Ju Hye ^a   Jeong, Yong Tae ^a   Kim, Yong Deuk ^b   Li, Xian ^a   Lu, Yue ^a   Chang, Young Chae ^c   Son, Kun Ho ^d   Chang, Hyeun Wook ^a  

^a Yeungnam University   (South Korea)

^b Daegu Haany University   (South Korea)

^c Catholic University of Daegu   (South Korea)

^d Andong National University   (South Korea)

Author keywords

AMP activated protein kinase; Endoplasmic reticulum; Insulin resistance; L6 myotubes; Tanshinone IIA

Indexed keywords

BETA ACTIN; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; TANSHINONE IIA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG STRUCTURE; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GENE SILENCING; GENETIC TRANSFECTION; IMMUNOBLOTTING; IN VIVO STUDY; INSULIN RESISTANCE; MALE; METABOLIC DISORDER; MOUSE; MYOTUBE; NONHUMAN; PLANT ROOT; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CELL LINE; DITERPENES, ABIETANE; DRUGS, CHINESE HERBAL; ENDOPLASMIC RETICULUM STRESS; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; MALE; MICE; MICE, INBRED C57BL; MUSCLE FIBERS, SKELETAL; TUNICAMYCIN;

MUS;

EID: 84872871569     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.12.066     Document Type: Article

References (38)

1. Ozcan U., Cao Q., Yilmaz E., Lee A.H., Iwakoshi N.N., Ozdelen E., Tuncman G., Gorgun C., Glimcher L.H., Hotamisligil G.S. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 2004, 306:457-461.
2. Nakatani Y., Kaneto H., Kawamori D., Yoshiuchi K., Hatazaki M., Matsuoka T.A., Ozawa K., Ogawa S., Hori M., Yamasaki Y., Matsuhisa M. Involvement of endoplasmic reticulum stress in insulin resistance and diabetes. J. Biol. Chem. 2005, 280:847-851.
3. Ozawa K., Miyazaki M., Matsuhisa M., Takano K., Nakatani Y., Hatazaki M., Tamatani T., Yamagata K., Miyagawa J., Kitao Y., Hori O., Yamasaki Y., Ogawa S. The endoplasmic reticulum chaperone improves insulin resistance in type 2 diabetes. Diabetes 2005, 54:657-663.
4. Ozcan U., Yilmaz E., Ozcan L., Furuhashi M., Vaillancourt E., Smith R.O., Gorgun C.Z., Hotamisligil G.S. Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science 2006, 313:1137-1140.
5. Rose A.J., Richter E.A. Skeletal muscle glucose uptake during exercise: how is it regulated?. Physiology (Bethesda) 2005, 20:260-270.
6. Yu C., Chen Y., Cline G.W., Zhang D., Zong H., Wang Y., Bergeron R., Kim J.K., Cushman S.W., Cooney G.J., Atcheson B., White M.F., Kraegen E.W., Shulman G.I. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J. Biol. Chem. 2002, 277:50230-50236.
7. Cho H., Mu J., Kim J.K., Thorvaldsen J.L., Chu Q., Crenshaw E.B., Kaestner K.H., Bartolomei M.S., Shulman G.I., Birnbaum M.J. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science 2001, 292:1728-1731.
8. Hayashi T., Hirshman M.F., Kurth E.J., Winder W.W., Goodyear L.J. Evidence for 5' AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport. Diabetes 1998, 47:1369-1373.
9. Jorgensen S.B., Viollet B., Andreelli F., Frosig C., Birk J.B., Schjerling P., Vaulont S., Richter E.A., Wojtaszewski J.F. Knockout of the alpha2 but not alpha1 5'-AMP-activated protein kinase isoform abolishes 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranosidebut not contraction-induced glucose uptake in skeletal muscle. J. Biol. Chem. 2004, 279:1070-1079.
10. Hardie D.G., Scott J.W., Pan D.A., Hudson E.R. Management of cellular energy by the AMP-activated protein kinase system. FEBS Lett. 2003, 546:113-120.
11. Carling D. The AMP-activated protein kinase cascade-a unifying system for energy control. Trends Biochem. Sci. 2004, 29:18-24.
12. Mu J., Brozinick J.T., Valladares O., Bucan M., Birnbaum M.J. A role for AMP-activated protein kinase in contraction- and hypoxia-regulated glucose transport in skeletal muscle. Mol. Cell 2001, 7:1085-1094.
13. Merrill G.F., Kurth E.J., Hardie D.G., Winder W.W. AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. Am. J. Physiol. 1997, 273:E1107-1112.
14. Russell R.R., Bergeron R., Shulman G.I., Young L.H. Translocation of myocardial GLUT-4 and increased glucose uptake through activation of AMPK by AICAR. Am. J. Physiol. 1999, 277:H643-649.
15. Zhou G., Myers R., Li Y., Chen Y., Shen X., Fenyk-Melody J., Wu M., Ventre J., Doebber T., Fujii N., Musi N., Hirshman M.F., Goodyear L.J., Moller D.E. Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest. 2001, 108:1167-1174.
16. Fryer L.G., Parbu-Patel A., Carling D. The Anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways. J. Biol. Chem. 2002, 277:25226-25232.
17. Jang S.I., Jeong S.I., Kim K.J., Kim H.J., Yu H.H., Park R., Kim H.M., You Y.O. Tanshinone IIA from salvia miltiorrhiza inhibits inducible nitric oxide synthase expression and production of TNF-alpha, IL-1beta and IL-6 in activated RAW 264.7 cells. Planta Med. 2003, 69:1057-1059.
18. Zhou G., Jiang W., Zhao Y., Ma G., Xin W., Yin J., Zhao B. Sodium tanshinone IIA sulfonate mediates electron transfer reaction in rat heart mitochondria. Biochem. Pharmacol. 2003, 65:51-57.
19. Ji X.Y., Tan B.K., Zhu Y.Z. Salvia miltiorrhiza and ischemic diseases. Acta Pharmacol. Sin. 2000, 21:1089-1094.
20. Jang S.I., Kim H.J., Kim Y.J., Jeong S.I., You Y.O. Tanshinone IIA inhibits LPS-induced NF-kappaB activation in RAW 264.7 cells: possible involvement of the NIK-IKK, ERK1/2, p38 and JNK pathways. Eur. J. Pharmacol. 2006, 542:1-7.
21. Trinh H.T., Chae S.J., Joh E.H., Son K.H., Jeon S.J., Kim D.H. Tanshinones isolated from the rhizome of Salvia miltiorrhiza inhibit passive cutaneous anaphylaxis reaction in mice. J. Ethnopharmacol. 2010, 132:344-348.
22. Somwar R., Sweeney G., Ramlal T., Klip A. Stimulation of glucose and amino acid transport and activation of the insulin signaling pathways by insulin lispro in L6 skeletal muscle cells. Clin. Ther. 1998, 20:125-140.
23. Hwang S.L., Chang H.W., Lee I.K., Yang B.K., Magae J., Chang Y.C. Ascofuranone prevents ER stress-induced insulin resistance via activation of AMP-activated protein kinase in L6 myotube cells. Biochem. Biophys. Res. Commun. 2010, 396:967-972.
24. Shen X., Ellis R.E., Lee K., Liu C.Y., Yang K., Solomon A., Yoshida H., Morimoto R., Kurnit D.M., Mori K., Kaufman R.J. Complementary signaling pathways regulate the unfolded protein response and are required for C. elegans development. Cell 2001, 107:893-903.
25. Hirosumi J., Tuncman G., Chang L., Gorgun C.Z., Uysal K.T., Maeda K., Karin M., Hotamisligil G.S. A central role for JNK in obesity and insulin resistance. Nature 2002, 420:333-336.
26. Rahman S.M., Qadri I., Janssen R.C., Friedman J.E. Fenofibrate and PBA prevent fatty acid-induced loss of adiponectin receptor and pAMPK in human hepatoma cells and in hepatitis C virus-induced steatosis. J. Lipid Res. 2009, 50:2193-2202.
27. Koh H.J., Arnolds D.E., Fujii N., Tran T.T., Rogers M.J., Jessen N., Li Y., Liew C.W., Ho R.C., Hirshman M.F., Kulkarni R.N., Kahn C.R., Goodyear L.J. Skeletal muscle-selective knockout of LKB1 increases insulin sensitivity, improves glucose homeostasis, and decreases TRB3. Mol. Cell. Biol. 2006, 26:8217-8227.
28. Sakamoto K., McCarthy A., Smith D., Green K.A., Grahame Hardie D., Ashworth A., Alessi D.R. Deficiency of LKB1 in skeletal muscle prevents AMPK activation and glucose uptake during contraction. EMBO J. 2005, 24:1810-1820.
29. Hawley S.A., Boudeau J., Reid J.L., Mustard K.J., Udd L., Makela T.P., Alessi D.R., Hardie D.G. Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade. J. Biol. 2003, 2:28.
30. Woods A., Johnstone S.R., Dickerson K., Leiper F.C., Fryer L.G., Neumann D., Schlattner U., Wallimann T., Carlson M., Carling D. LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr. Biol. 2003, 13:2004-2008.
31. Ling S., Dai A., Guo Z., Komesaroff P.A. A preparation of herbal medicine Salvia miltiorrhiza reduces expression of intercellular adhesion molecule-1 and development of atherosclerosis in apolipoprotein E-deficient mice. J. Cardiovasc. Pharmacol. 2008, 51:38-44.
32. Yu C.M., Chan J.C., Sanderson J.E. Chinese herbs and warfarin potentiation by 'danshen'. J. Intern. Med. 1997, 241:337-339.
33. Liu Y., Wang L., Li X., Lv C., Feng D., Luo Z. Tanshinone IIA improves impaired nerve functions in experimental diabetic rats. Biochem. Biophys. Res. Commun. 2010, 399:49-54.
34. Zhang Y., Wei L., Sun D., Cao F., Gao H., Zhao L., Du J., Li Y., Wang H. Tanshinone IIA pretreatment protects myocardium against ischaemia/reperfusion injury through the phosphatidylinositol 3-kinase/Akt-dependent pathway in diabetic rats. Diabetes Obes. Metab. 2010, 12:316-322.
35. Pan C., Lou L., Huo Y., Singh G., Chen M., Zhang D., Wu A., Zhao M., Wang S., Li J. Salvianolic acid B and tanshinone IIA attenuate myocardial ischemia injury in mice by NO production through multiple pathways. Ther. Adv. Cardiovasc. Dis. 2011, 5:99-111.
36. Muoio D.M., Newgard C.B. Biomedicine. Insulin resistance takes a trip through the ER. Science 2004, 306:425-426.
37. Cusi K., Maezono K., Osman A., Pendergrass M., Patti M.E., Pratipanawatr T., DeFronzo R.A., Kahn C.R., Mandarino L.J. Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle. J. Clin. Invest. 2000, 105:311-320.
38. Shulman G.I. Cellular mechanisms of insulin resistance. J. Clin. Invest. 2000, 106:171-176.